CTNM vs MTCH · $429.6M cap vs P/E 13, rev $1.72B
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) versus Match Group Inc (MTCH) — a side-by-side from cached financials, not a winner call.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company listed on US.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
Latest reported CTNM revenue for 2024-09-30 was $0. Net income was -$27.7M. CTNM currently screens at market cap $429.6M.
Latest reported MTCH revenue for 2026-06-30 was $1.72B. Net income was $337.4M. Revenue was up 98.7% from 2026-03-31 to 2026-06-30. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
CTNM currently screens at market cap $429.6M. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Not investment advice. Open the CTNM and MTCH stock pages for the full models.
Not investment advice.